Regencell Bioscience Ownership | Who Owns Regencell Bioscience?


OverviewForecastChart

Regencell Bioscience Ownership Summary


Regencell Bioscience is owned by 0.10% institutional investors, 88.55% insiders, and 11.35% retail investors. Squarepoint ops is the largest institutional shareholder, holding 0.39% of RGC shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in Regencell Bioscience shares.

RGC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRegencell Bioscience0.10%88.55%11.35%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.25%11.78%67.97%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Squarepoint ops51.25K0.39%$791.80K
Discovery capital management, llc / ct46.17K0.35%$713.26K
Xtx topco38.73K0.30%$598.46K
Vident advisory18.07K0.14%$279.15K
Geode capital management413.08K0.08%$8.67M
Gsa capital partners llp31.57K0.01%$803.00K
Ubs group23.89K0.00%$607.40K
Morgan stanley21.42K0.00%$449.90K
Tower research capital llc (trc)357.000.00%$5.52K
Legal & general group9.90K0.00%$251.83K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Gsa capital partners llp31.57K0.05%$803.00K
Discovery capital management, llc / ct46.17K0.04%$713.26K
Xtx topco38.73K0.03%$598.46K
Vident advisory18.07K0.00%$279.15K
Squarepoint ops51.25K0.00%$791.80K
Geode capital management413.08K0.00%$8.67M
Gf fund management1.06K0.00%$27.06K
Eversource wealth advisors550.000.00%$11.55K
Tower research capital llc (trc)357.000.00%$5.52K
Bell investment advisors20.000.00%$509.00

Top Buyers

HolderShares% AssetsChange
Discovery capital management, llc / ct46.17K0.04%46.17K
Xtx topco38.73K0.03%38.73K
Gsa capital partners llp31.57K0.05%31.57K
Vident advisory18.07K0.00%18.07K
Legal & general group9.90K0.00%9.90K

Top Sellers

HolderShares% AssetsChange
Schonfeld strategic advisors---52.10K
Squarepoint ops51.25K0.00%-48.59K
Morgan stanley21.42K--16.42K
Y-intercept (hong kong)---13.04K
Greenfield savings bank---11.00K

New Positions

HolderShares% AssetsChangeValue
Discovery capital management, llc / ct46.17K0.04%46.17K$713.26K
Xtx topco38.73K0.03%38.73K$598.46K
Gsa capital partners llp31.57K0.05%31.57K$803.00K
Vident advisory18.07K0.00%18.07K$279.15K
Legal & general group9.90K0.00%9.90K$251.83K

Sold Out

HolderChange
Qube research-13.00
Citigroup-70.00
Raymond james financial-71.00
Group one trading-100.00
Simplex trading-217.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202510-52.38%485,100-23.46%-0.41%6-53.85%3-40.00%
Sep 30, 20252161.54%633,811-3.78%419.01%13-5-
Jun 30, 202513160.00%691,5287731.57%5115339.76%13225.00%--100.00%
Mar 31, 2025566.67%8,830-72.02%-115.38%4100.00%1-
Dec 31, 2024350.00%31,55674.21%-1251.51%2---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index296.69K0.06%4.59K
Fidelity Nasdaq Composite ETF120.06K0.02%-
L&G Asia Pacific ex Japan Equity ETF9.50K0.00%-
Amundi Prime Global ETF Dist6.94K0.00%-
TD International Equity Index ETF4.90K0.00%-
Amundi Prime All Country World ETF Inc4.15K0.00%-
State Street® SPDR® S&P® China ETF3.90K0.00%-
Desjardins International Equity Idx ETF2.23K0.00%-
BNY Mellon International Equity ETF1.25K0.00%-
Goldman Sachs MarketBeta Intl Eq ETF1.46K0.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 29, 2017BELL THOMAS D JR-Buy$369.00K
Aug 25, 2017KAPLAN STEPHEN A-Buy$148.70K
Aug 24, 2017Ownby David EVP, CFO and TreasurerBuy$105.30K
Mar 09, 2017BRANDOW PETER B EVP, General Counsel, Sec.Sell$455.24K
Mar 09, 2017DUNN GREGORY W President and COOSell$577.01K

Insider Transactions Trends


DateBuySell
2026 Q1--
2018 Q1--
2017 Q4--
2017 Q33-
2017 Q1-2

RGC Ownership FAQ


Who Owns Regencell Bioscience?

Regencell Bioscience shareholders are primarily institutional investors at 0.10%, followed by 88.55% insiders and 11.35% retail investors. The average institutional ownership in Regencell Bioscience's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.25%, which Regencell Bioscience falls below.

Who owns the most shares of Regencell Bioscience?

Regencell Bioscience’s largest shareholders are Squarepoint ops (51.25K shares, 0.39%), Discovery capital management, llc / ct (46.17K shares, 0.35%), and Xtx topco (38.74K shares, 0.30%). Together, they hold 1.05% of Regencell Bioscience’s total shares outstanding.

Does Blackrock own Regencell Bioscience?

BlackRock is not among the top 10 institutional shareholders of Regencell Bioscience.

Who is Regencell Bioscience’s biggest shareholder by percentage of total assets invested?

Gsa capital partners llp is Regencell Bioscience’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 31.57K Regencell Bioscience shares, valued at 803K$.

Who is the top mutual fund holder of Regencell Bioscience shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Regencell Bioscience shares, with 0.06% of its total shares outstanding invested in 296.69K Regencell Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools